Hemoglobinemia

Hemoglobinemia
Hemoglobin

Hemoglobinemia (or haemoglobinaemia) is a medical condition in which there is an excess of hemoglobin in the blood plasma. This is an effect of intravascular hemolysis, in which hemoglobin separates from red blood cells, a form of anemia.

Hemoglobinemia can be caused by intrinsic or extrinsic factors. When hemoglobinemia is internally caused, it is a result of recessive genetic defects that cause the red blood cells to lyse, letting the hemoglobin spill out of the cell into the blood plasma.

In intravascular hemolysis, hemoglobin is released and binds with haptoglobin. This causes haptoglobin levels to decrease. Once haptoglobin is saturated, free hemoglobin readily distributes to tissues where it might be exposed to oxidative conditions. In such conditions, heme can be released from ferric hemoglobin. The free heme can then accelerate tissue damage by promoting peroxidative reactions and activation of inflammatory cascades. Hemopexin (Hx) is another plasma glycoprotein able to bind heme with high affinity. Hx sequesters heme in an inert, non-toxic form and transports it to the liver for catabolism and excretion.[1] As long as both haptoglobin and hemopexin are saturated, the remaining free hemoglobins are filtered in the kidney and some of them will be reabsorbed by way of proximal tubules.

In externally caused hemoglobinemia, an outside attacker acts as an antibody against the red blood cells. This can cause the cells to be destroyed and their hemoglobin released. In extravascular hemolysis, red blood cells are phagocytized by macrophages in the spleen and liver.[2]

Abnormal value of hemoglobin does not necessarily indicate a medical problem needing treatment.[3] Diet, activity level, medications, a women's menstrual cycle, and other considerations can affect the results.[3] Additionally to these, one may have higher than normal hemoglobin if they live in a high altitude area.[3]

  1. ^ Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW (2014-10-28). "Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development". Frontiers in Physiology. 5. Frontiers Media SA: 415. doi:10.3389/fphys.2014.00415. PMC 4211382. PMID 25389409.
  2. ^ Interactive, Wellfire. "Pathology Thread". www.med-ed.virginia.edu. Retrieved 2018-04-11.
  3. ^ a b c Cite error: The named reference MedlinePlus 2019 was invoked but never defined (see the help page).